Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.73 Up 0.04(2.37%) Apr 17, 4:00PM EDT
|After Hours : 1.73 0.00 (0.00%) Apr 17, 4:29PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingApr 30, 2013Apr 30, 2012Apr 30, 2011
Total Revenue 21,683   15,233   13,492  
Cost of Revenue12,595  10,153  7,296  
Gross Profit 9,088   5,080   6,196  
Operating Expenses
Research Development24,306  35,688  29,462  
Selling General and Administrative13,134  11,462  11,421  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (28,352) (42,070) (34,687)
Income from Continuing Operations
Total Other Income/Expenses Net(1,374)41  1,052  
Earnings Before Interest And Taxes(28,030)(42,029)(33,635)
Interest Expense54  90  516  
Income Before Tax(28,084)(42,119)(34,151)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(29,780)(42,119)(34,151)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (29,780) (42,119) (34,151)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (29,780) (42,119) (34,151)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.